DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...
A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic ...
Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...
The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...
Rebuilding the reciprocal care-oriented relationships between Amazonian Indigenous peoples and nature could address the predicted effects of climate change on biodiversity.